Nothing Special   »   [go: up one dir, main page]

ATE285775T1 - Behandlung diabetischer ulcera - Google Patents

Behandlung diabetischer ulcera

Info

Publication number
ATE285775T1
ATE285775T1 AT01900568T AT01900568T ATE285775T1 AT E285775 T1 ATE285775 T1 AT E285775T1 AT 01900568 T AT01900568 T AT 01900568T AT 01900568 T AT01900568 T AT 01900568T AT E285775 T1 ATE285775 T1 AT E285775T1
Authority
AT
Austria
Prior art keywords
diabetic
treatment
ulceras
ulcers
inhibitors
Prior art date
Application number
AT01900568T
Other languages
English (en)
Inventor
Ralph E Wood
Michael John Davies
Richard Lewis Siegel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE285775T1 publication Critical patent/ATE285775T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01900568T 2000-01-11 2001-01-11 Behandlung diabetischer ulcera ATE285775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000561.1A GB0000561D0 (en) 2000-01-11 2000-01-11 Treatment of diabetic ulcers
PCT/IB2001/000018 WO2001051042A2 (en) 2000-01-11 2001-01-11 Treatment of diabetic ulcers

Publications (1)

Publication Number Publication Date
ATE285775T1 true ATE285775T1 (de) 2005-01-15

Family

ID=9883498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01900568T ATE285775T1 (de) 2000-01-11 2001-01-11 Behandlung diabetischer ulcera

Country Status (15)

Country Link
US (1) US20030176442A1 (de)
EP (1) EP1248623B1 (de)
JP (1) JP2003519652A (de)
KR (1) KR20020082841A (de)
AT (1) ATE285775T1 (de)
AU (1) AU2540301A (de)
CA (1) CA2396120A1 (de)
DE (1) DE60108068T2 (de)
ES (1) ES2233599T3 (de)
GB (1) GB0000561D0 (de)
HU (1) HUP0204097A2 (de)
IL (1) IL150395A0 (de)
NZ (1) NZ519722A (de)
WO (1) WO2001051042A2 (de)
ZA (1) ZA200205694B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0020588D0 (en) * 2000-08-21 2000-10-11 Pfizer Ltd Treatment of wounds
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
GB0129274D0 (en) * 2001-12-06 2002-01-23 Pfizer Ltd Novel kit
US8133903B2 (en) 2003-10-21 2012-03-13 Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases
CA2519357A1 (en) * 2003-03-17 2004-09-30 Pfizer Products Inc. Treatment of type 1 diabetes with pde5 inhibitors
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
US10143694B2 (en) 2006-10-27 2018-12-04 Matthew H. Kopacki Advanced formulations and therapies for treating hard-to-heal wounds
US20090163504A1 (en) * 2006-10-27 2009-06-25 Kopacki Matthew H Method for healing a wound using a phosphodiesterase type five inhibitor
CN102970965A (zh) 2010-04-05 2013-03-13 Sk化学公司 含有pde5抑制剂的减少皮肤皱纹的合成物
AT512084A1 (de) 2011-10-20 2013-05-15 Univ Wien Tech Diazabicyclo- und diazaspiro-alkanderivate als phosphodiesterase-5 inhibitoren
MX2017016930A (es) * 2017-12-19 2019-06-20 Malesil Research & Tech Llc Uso del maleato de sildenafil en el tratamiento de ulceras de pie diabetico.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ324834A (en) * 1995-12-28 2001-11-30 Fujisawa Pharmaceutical Co Benzimidazole derivatives and their use in reducing blood sugar or as inhibitors of PDE5 activity
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6043252A (en) * 1997-05-05 2000-03-28 Icos Corporation Carboline derivatives
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
PT1371647E (pt) * 1998-04-20 2005-10-31 Pfizer Derivados do acido piridina-3-carboxilico e sua utilizacao como intermediarios
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
IT1312310B1 (it) * 1999-05-07 2002-04-15 Recordati Ind Chimica E Farma Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
US6075028A (en) * 1999-09-23 2000-06-13 Graham; Richard Method of treating Tourette's syndrome and related CNS disorders
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
US6271228B1 (en) * 2000-04-28 2001-08-07 Pfizer Inc. Blood pressure stabilization during hemodialysis
US20030105108A1 (en) * 2002-12-19 2003-06-05 Wood Ralph E. Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds

Also Published As

Publication number Publication date
DE60108068T2 (de) 2005-12-08
US20030176442A1 (en) 2003-09-18
EP1248623B1 (de) 2004-12-29
DE60108068D1 (de) 2005-02-03
HUP0204097A2 (hu) 2003-04-28
JP2003519652A (ja) 2003-06-24
AU2540301A (en) 2001-07-24
ZA200205694B (en) 2003-08-11
WO2001051042A2 (en) 2001-07-19
GB0000561D0 (en) 2000-03-01
IL150395A0 (en) 2002-12-01
NZ519722A (en) 2004-12-24
EP1248623A2 (de) 2002-10-16
WO2001051042A3 (en) 2002-01-10
CA2396120A1 (en) 2001-07-19
ES2233599T3 (es) 2005-06-16
KR20020082841A (ko) 2002-10-31

Similar Documents

Publication Publication Date Title
CY1105390T1 (el) Θepαπευτικη αγωγη της πνευμονικης υπερτασης
EP1129706A3 (de) Verwendung von cGMP-PDE5-Hemmern zur Behandlung der Neuropathie
CY1123084T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι
CY1110784T1 (el) Ιατρικη χρηση της τετρα-υδροτριαζολο[4,3-α]πυραζινης
ATE283856T1 (de) Zyklische guanosine 3',5'-monophosphate phosphodiesterase inhibitoren
HN2002000317A (es) Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
DK1200418T3 (da) Nematodicide trifluorbutener
DE69911448D1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200501690A1 (ru) Композиция, включающая ингибитор pde4 и ингибитор pde5
DE60108068D1 (de) Behandlung diabetischer ulcera
BR0307410A (pt) Uso de inibidores de pde5 no tratamento da cicatrização e fibrose
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
SE0004101D0 (sv) New use
DE60111254D1 (de) Verwendung von pde5 inhibitoren zur behandlung vorzeitiger ejakulation
MY127989A (en) Treatment of neuropathy
CY1111319T1 (el) Ενωση 4-μεθυλεξανοϊκης κααλαλιδης f

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties